載入...
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
PURPOSE: Estimating risk of late distant recurrence (DR) is an important goal for managing women with hormone receptor–positive breast cancer after 5 years of endocrine treatment without recurrence. We developed and validated a simple clinicopathologic tool (Clinical Treatment Score post–5 years [CT...
Na minha lista:
| 發表在: | J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Clinical Oncology
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6049399/ https://ncbi.nlm.nih.gov/pubmed/29676944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.76.4258 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|